Luoxin Pharmaceuticals Group Stock Co., Ltd.
SZSE:002793.SZ
5.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 456.677 | 692.899 | 1,433.805 | 2,001.722 | 1,287.575 | 1,108.523 | 323.353 | 125.76 | 140.127 | 79.971 | 48.878 | 52.645 | 64.179 | 65.303 |
| Short Term Investments
| 1.25 | 2.1 | 17.1 | 12.579 | -98.987 | 106.841 | 83.043 | 1.296 | 0.006 | 1,049.556 | 0.279 | 1,155 | 2.191 | 0 |
| Cash and Short Term Investments
| 457.928 | 694.999 | 1,450.905 | 2,014.301 | 1,287.575 | 1,215.364 | 323.353 | 127.056 | 140.133 | 79.971 | 49.157 | 52.645 | 66.37 | 65.303 |
| Net Receivables
| 662.934 | 598.888 | 996.3 | 3,255.191 | 2,619.142 | 2,344.319 | 0 | 141.214 | 0 | 120.863 | 99.084 | 73.396 | 0 | 0 |
| Inventory
| 459.556 | 455.611 | 684.986 | 709.077 | 645.814 | 740.917 | 193.222 | 179.726 | 150.58 | 106.889 | 97.794 | 81.436 | 97.425 | 94.391 |
| Other Current Assets
| 203.963 | 318.012 | 1,589.702 | 389.819 | 329.215 | 623.164 | 0 | 29.183 | 0 | 8.043 | 0.978 | 4.125 | 67.82 | 44.732 |
| Total Current Assets
| 1,784.38 | 2,067.511 | 4,721.893 | 6,368.388 | 4,880.401 | 4,873.967 | 817.228 | 477.179 | 526.401 | 315.765 | 247.014 | 211.602 | 231.615 | 204.426 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 1,296.476 | 1,629.549 | 1,777.273 | 2,071.069 | 1,921.466 | 1,754.938 | 390.201 | 226.151 | 207.859 | 158.108 | 124.267 | 75.994 | 65.302 | 60.358 |
| Goodwill
| 1.953 | 1.953 | 4.378 | 9.757 | 8.81 | 6.385 | 6.385 | 0 | 0.165 | 0.165 | 0.165 | 0.165 | 0.165 | 0 |
| Intangible Assets
| 674.397 | 701.151 | 646.47 | 650.295 | 601.879 | 513.859 | 186.941 | 191.391 | 74.462 | 71.634 | 73.164 | 74.512 | 74.755 | 6.126 |
| Goodwill and Intangible Assets
| 676.35 | 703.104 | 650.848 | 660.051 | 610.69 | 520.244 | 186.941 | 191.391 | 74.462 | 71.634 | 73.164 | 74.512 | 74.755 | 6.126 |
| Long Term Investments
| 241.866 | 369.549 | 214.861 | 52.664 | 165.642 | -44.055 | -28.824 | 0 | 89.335 | 70.287 | 41 | 41 | 1 | 0 |
| Tax Assets
| 188.391 | 286.15 | 417.543 | 183.669 | 126.055 | 136.364 | 7.353 | 4.104 | 3.977 | 4.093 | 3.416 | 1.193 | 0.636 | 1.032 |
| Other Non-Current Assets
| 148.515 | 61.543 | 325.408 | 160.989 | 17.445 | 219.102 | 28.833 | 0.101 | -89.141 | -70.287 | -41 | -41 | -1 | 0 |
| Total Non-Current Assets
| 2,551.598 | 3,049.896 | 3,385.932 | 3,128.442 | 2,841.298 | 2,586.593 | 584.504 | 421.748 | 286.492 | 233.835 | 200.846 | 151.699 | 140.693 | 67.515 |
| Total Assets
| 4,335.978 | 5,117.407 | 8,107.824 | 9,496.83 | 7,721.7 | 7,460.56 | 1,401.732 | 898.927 | 812.893 | 549.6 | 447.86 | 363.302 | 372.308 | 271.941 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 544.097 | 384.894 | 512.252 | 184.141 | 19.825 | 1,094.241 | 636.951 | 83.919 | 74.488 | 77.124 | 68.415 | 70.41 | 76.181 | 71.281 |
| Short Term Debt
| 742.079 | 555.603 | 2,378.253 | 2,427.973 | 1,420.426 | -606.135 | 110 | 0 | 0 | 100.42 | 13.142 | 22.194 | 74.714 | 21.472 |
| Tax Payables
| 39.02 | 1.79 | 22.595 | 228.54 | 237.696 | 226.475 | 9.658 | 12.691 | 9.632 | 6.431 | 5.577 | 3.576 | 0.09 | 11.87 |
| Deferred Revenue
| 0 | 0 | 169.283 | 864.427 | 973.392 | 966.865 | 9.658 | 30.191 | 17.432 | 24.301 | 24.355 | 12.445 | 7.959 | 17.809 |
| Other Current Liabilities
| 1,212.789 | 975.269 | 1,461.719 | 1,220.028 | 1,451.527 | -117.545 | 1,941.033 | 43.209 | 27.747 | 26.129 | 27.225 | 15.622 | 15.46 | 15.449 |
| Total Current Liabilities
| 2,537.985 | 1,917.556 | 4,374.818 | 4,007.277 | 2,966.714 | 2,950.916 | 247.218 | 139.819 | 111.866 | 210.104 | 114.359 | 111.802 | 166.444 | 120.072 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 167.069 | 468.306 | 253.81 | 624.26 | 303.327 | 463.981 | 0 | 0 | 0 | 0 | 18 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 78.92 | 89.934 | 93.581 | 102.224 | 101.299 | 83.908 | 26.177 | 4.728 | 2.692 | 0 | -18 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 7.358 | 7.585 | 0 | -0 | 303.327 | -463.981 | -218.451 | 0.194 | 0.001 | 0 | 0.042 | 0 | 0.329 | 0 |
| Other Non-Current Liabilities
| 85.242 | 151.551 | 183.008 | 27.279 | 162.847 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 338.589 | 627.442 | 426.528 | 753.763 | 404.626 | 547.889 | 244.628 | 4.922 | 2.693 | 0 | 18.042 | 0 | 0.329 | 0 |
| Total Liabilities
| 2,876.574 | 2,544.998 | 4,801.346 | 4,761.04 | 3,371.341 | 3,498.806 | 491.846 | 144.742 | 114.559 | 210.104 | 132.401 | 111.802 | 166.773 | 120.072 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 40.771 | 66.331 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1,087.588 | 1,087.588 | 1,087.588 | 1,463.689 | 1,467.223 | 1,435.176 | 200 | 200 | 100 | 75 | 75 | 75 | 75 | 54.945 |
| Retained Earnings
| -90.281 | 875.215 | 1,535.576 | 2,788.9 | 2,440.241 | 2,191.445 | 378.026 | 297.794 | 253.511 | 163.148 | 147.249 | 89.667 | 48.3 | 63.193 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 40.677 | 42.733 | -40.771 | -66.331 | 52.457 | 59.916 | 46.048 | 34.478 | 101.348 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 384.97 | 466.421 | 551.72 | 134.74 | 204.374 | 0 | 0 | 210.344 | 310.344 | 101.348 | 93.21 | 86.832 | 96.276 | 33.731 |
| Total Shareholders Equity
| 1,382.277 | 2,469.901 | 3,174.106 | 4,384.587 | 4,040.506 | 3,679.079 | 909.886 | 754.185 | 698.334 | 339.496 | 315.459 | 251.5 | 205.536 | 151.869 |
| Total Equity
| 1,459.404 | 2,572.409 | 3,306.478 | 4,735.789 | 4,350.359 | 3,961.755 | 1,119.952 | 754.185 | 746.552 | 358.756 | 319.255 | 254.984 | 207.433 | 151.869 |
| Total Liabilities & Shareholders Equity
| 4,335.978 | 5,117.407 | 8,107.824 | 9,496.83 | 7,721.7 | 7,460.56 | 1,401.732 | 898.927 | 812.893 | 549.6 | 447.86 | 363.302 | 372.308 | 271.941 |